Mankind Pharma Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Mankind Pharma Limited generated cash of $21,524,450,000, which is more than the previous year. Cash used in financing activities reached the amount of $52,656,000 last year. Net change in cash is therefore $771,868,000.
Cash Flow
| 2020 | 10.69B | -4.39B | -5.30B |
|---|---|---|---|
| 2021 | 11.37B | -12.22B | -78.11M |
| 2023 | 17.84B | -10.66B | -6.98B |
| 2024 | 21.52B | -20.81B | 52.65M |
MANKIND.NS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 3.04B | 3.02B | 2.19B | 1.16B |
Operating activities | ||||
Net income | 19.12B | 12.81B | 16.91B | 14.37B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 3.98B | 3.25B | 1.18B | 990.59M |
Stock-based compensation expense | 231.86M | 591K | 0 | 0 |
| Deferred income tax benefit | 231.86M | 591K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -2.89B | -2.05B | 2.00B | -3.08B |
Inventories | -550.03M | 2.61B | -2.84B | -781.49M |
Accounts payable | 974.52M | -650.19M | -781.53M | 1.83B |
Cash generated by operating activities | 21.52B | 17.84B | 11.37B | 10.69B |
Investing activities | ||||
Purchases Of Investments | -16.30B | -9.48B | -9.95B | -5.72B |
Investments In Property Plant And Equipment | -3.89B | -8.32B | -3.12B | -2.27B |
Acquisitions Net | 73.95M | 22.20M | 102.7M | 52.97M |
Cash generated by investing activities | -20.81B | -10.66B | -12.22B | -4.39B |
Financing activities | ||||
Common Stock Issued | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | -3.64B |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 339.63M | -6.95B | -4.68B | -1.39B |
Cash used in financing activities | 52.65M | -6.98B | -78.11M | -5.30B |
Net Change In Cash | 771.86M | 22.86M | -924.03M | 1.03B |
Cash at end of period | 3.82B | 3.04B | 1.27B | 2.19B |
| Data source | Data source | Data source | Data source |